Phase 4 Sleep Disorders Trial, Recruiting NCT04118387 Sponsor: VA Office of Research and Development Condition: Sleep Disorders
Back to Sleep Disorders

Phase 4 Sleep Disorders Trial, Recruiting

NCT04118387
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are military Veterans (men or women) and have been diagnosed with central sleep apnea, meaning their sleep breathing test shows more than 15 breathing pauses per hour overall, with more than 5 of those per hour being the "central" type (where the brain fails to send the signal to breathe)

Who may not be able to join:

  • People under 18 years of age
  • People who are pregnant or breastfeeding
  • People with severe lung or breathing disease that requires them to use supplemental oxygen
  • People who have had a recent health event that may affect their ability to take part in the study (confirm with trial site)
  • People whose Body Mass Index (BMI) — a measure of body weight relative to height — is above 40
  • People with significant insomnia (serious ongoing difficulty sleeping)
  • People experiencing significant mental health instability (confirm with trial site)
  • People who have had a recent health event that may affect their sleep (confirm with trial site)
  • People for whom the lead researcher determines that a particular study medication is not appropriate, or who are unable to use the breathing device used to treat sleep apnea in this study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: M Safwan Badr, MD, John D. Dingell VA Medical Center, Detroit, MI

Phone: (313) 576-1000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
7 January 2021
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

CO2 reserve; Central apnea indices

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov